HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New observations in primary and secondary reading epilepsy: excellent response to levetiracetam and early spontaneous remission.

Abstract
The response of reading epilepsy to new antiepileptic drugs is not known. Due to the rarity of this condition little is known about its natural history. We evaluated and treated three patients with primary and secondary reading epilepsy. Seizures in all patients were characterized by twitching of the jaw or lips with secondarily generalized tonic-clonic seizures if reading continued. One patient with primary reading epilepsy became seizure-free with divalproex monotherapy and another with levetiracetam monotherapy after failure of lamotrigine. One other patient with secondary reading epilepsy became seizure-free with levetiracetam add-on therapy. The divalproex-treated patient stopped therapy less than 3 years after seizure onset and remained seizure-free with 6 years of follow-up. We propose levetiracetam as a first-line treatment for primary and secondary reading epilepsy. Spontaneous medication-free remission of primary reading epilepsy may occur within 3 years of seizure onset, much earlier than previously reported.
AuthorsM Ayman Haykal, Amro El-Feki, Hasan H Sonmezturk, Bassel W Abou-Khalil
JournalEpilepsy & behavior : E&B (Epilepsy Behav) Vol. 23 Issue 4 Pg. 466-70 (Apr 2012) ISSN: 1525-5069 [Electronic] United States
PMID22386591 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Anticonvulsants
  • Levetiracetam
  • Piracetam
Topics
  • Adolescent
  • Adult
  • Anticonvulsants (therapeutic use)
  • Electroencephalography
  • Epilepsy, Reflex (drug therapy, prevention & control)
  • Female
  • Follow-Up Studies
  • Humans
  • Levetiracetam
  • Male
  • Piracetam (analogs & derivatives, therapeutic use)
  • Secondary Prevention

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: